Clinical Trial Update: Adjuvant Radiotherapy in High Risk Locally Advanced DTC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant radiotherapy for high-risk locally advanced differentiated thyroid carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Thyroid Cancer | Phase 3 | Status: RECRUITING